Skip to main content

Table 2 Summary of TIGIT expresion in neoplastic cells of 12 poorly differentiated thyroid carcinomas (PDTCs)

From: Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma

case no

positive tumor cell morphology

TMN stage

immune cell

IHC score

type of infiltrate

density

predominant cell type

1

round nuclei

T4aN0M1

scattered

low

lymphcyte

1 + 

2

large and convoluted nuclei

T3NXM0

focal

low

lymphcyte

1 + 

3

round neclei

T3NXM0

scattered

low

lymphcyte

1 + 

4

round nuclei

T3N1bM0

scattered

low

lymphcyte

0

5

round or oval nuclei

T3N1bM1

scattered

low

lymphcyte

0

6

round or oval nuclei

T3NXM0

scattered

low

lymphcyte

0

7

round or oval nuclei

T2NXN0

scattered

low

lymphcyte

0

8

round nuclei

T3NXM0

scattered

low

lymphcyte

0

9

round or oval nuclei

T3N1aM0

scattered

low

lymphcyte

0

10

round and oval nuclei

T3NXM0

scattered

low

lymphcyte

0

11

large and convoluted nuclei

T3N1aM0

scattered

low

lymphcyte

0

12

round or oval nuclei

T3N0M0

focal

high

lymphcyte

0